EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Association of serum level of 25-hydroxy vitamin D with clinical activity and pulmonary involvement severity in patients with sarcoidosis

Keivan Gohari-Moghadam, Ali Majidi Nejad

Journal of the Selva Andina Research Society · 20.02.2026 · 17 (1) · 27-35

DOI: 10.36610/j.jsars.20261363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Selva Andina Research Society, online erschienen am 20.02.2026. Verfasst von Keivan Gohari-Moghadam und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We determined the role of measuring 25-hydroxy vitamin D to predict clinical activity and severity of pulmonary involvement in sarcoidosis. 61 consecutive patients with sarcoidosis were assessed. The serum level of 25 hydroxyvitamin D was measured using the chemiluminescent immunoassay. Sarcoid clinical activity classification (SCAC) was used to assess the clinical condition of the disease. The patients were also followed for 6 months. 14.8 % suffered severe 25-hydroxy vitamin D deficiency and 26.2 % had mild to moderate 25-hydroxy vitamin D deficiency. Serum phosphorus level was negatively associated with SCAC. There was also significant relationship between SCAC and pulmonary stages. The serum level of 25-hydroxy vitamin D was not associated with clinical activity. Within a 6-month follow-up time, clinical improvement of disease was overall achieved in 32 out of 61 patients leading success rate 52.5 %. Advanced age and stage 3-4 of pulmonary defects were main predictors for lack of 6-month clinical improvement in sarcoidosis patients. There is no relation between serum level of 25-hydroxy vitamin D and two indices of clinical activity of sarcoidosis and the severity of pulmonary involvement. The assessment of serum phosphorus and serum creatinine can be assessed to determine disease severity.

Zitieren

APA

Gohari-Moghadam, K., & Nejad, A. M. (2026). Association of serum level of 25-hydroxy vitamin D with clinical activity and pulmonary involvement severity in patients with sarcoidosis. Journal of the Selva Andina Research Society, 17(1), 27-35. https://doi.org/10.36610/j.jsars.20261363

Vancouver

Gohari-Moghadam K, Nejad AM. Association of serum level of 25-hydroxy vitamin D with clinical activity and pulmonary involvement severity in patients with sarcoidosis. Journal of the Selva Andina Research Society. 2026;17(1):27-35. doi:10.36610/j.jsars.20261363

BibTeX
@article{GohariMoghadam2026,
  author = {Gohari-Moghadam, Keivan and Nejad, Ali Majidi},
  title = {Association of serum level of 25-hydroxy vitamin D with clinical activity and pulmonary involvement severity in patients with sarcoidosis},
  journal = {Journal of the Selva Andina Research Society},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {27--35},
  doi = {10.36610/j.jsars.20261363}
}
Kostenlos starten →